Lidocaine exerts anticancer activity in bladder cancer by targeting isoprenylcysteine carboxylmethyltransferase (ICMT)

BACKGROUND: Bladder cancer is one of the most common malignant tumors among humans and has a high mortality. Clinically, lidocaine is the most commonly used local anesthetic, which can inhibit the proliferation of bladder cancer cells; however, its downstream specific molecular mechanisms are unclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Xiaodan, Liu, Yang, Wang, Liping, Wang, Guonian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661257/
https://www.ncbi.nlm.nih.gov/pubmed/34984187
http://dx.doi.org/10.21037/tau-21-893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661257/
https://www.ncbi.nlm.nih.gov/pubmed/34984187
http://dx.doi.org/10.21037/tau-21-893

Ejemplares similares